Our hospital system has been arranging frequent staff meetings to provide situational updates amid the pandemic. On 12/2/20, Evan Anderson (infectious disease) provided an an excellent update on COVID-19/rollout of vaccines.
Key Points:
- mRNA vaccines have been remarkably effective, both ~95% and also effective against severe disease (>90%)
- Severe reactogenicity occurs >2%. Systemic symptoms like fatigue, myalgia, and chills are more common after 2nd dose
- Local reactions are typically more pronounced than flu vaccine but less pronounced compared to shingles vaccine (Shingrix)
- Not wise to vaccinate entire care areas at same time
- No need to check antibody titers after vaccination
- Current contraindications: Pregnant women and children due to lack of data (Pfizer vaccine may be approved for those older than 12 yrs)
- Study participants were allowed to take antipyretics









Current pandemic situation in metro Atlanta (slide from Dan Salinas)

Related blog posts:
Pingback: Visual Data of Pfizer COVID-19 Vaccine | gutsandgrowth
Pingback: Vaccination Recommendations for IBD Patients | gutsandgrowth